Injective eyes $50 breakout after bullish MACD signal and US, EU regulatory wins
Injective (INJ), a decentralized blockchain platform focused on finance, is drawing renewed market interest as bullish technical and regulatory developments converge to support its expansion. The project, which enables decentralized derivatives, trading, and real-world asset tokenization, reported significant progress in both market performance and compliance in major jurisdictions.